Researching SynGenX for weaned pigs

"Antibiotic stewardship" was the key focus of the annual meeting of the American Association of Swine Veterinarians held recently in New Orleans. Veterinarians are leading the effort to optimize antibiotic use and preserve the efficacy of current therapeutic treatments. Interest is high in research evaluating natural alternatives to promote pig health.
 
In young pigs, pathogenic strains of E. coli and Salmonella are a particular challenge. New research presented to AASV included "Quantitative assessment of prevalence and severity to understand impact of Lactobacillus acidophilus fermentation product (SynGenX^®) in a herd with endemic (E. coli) K88 and Salmonella post-wean" by independent researcher Sarah Probst Miller, DVM and co-authors Iowa State University researcher Alex Ramirez, DVM, MPH, DACVPM and Diamond V researchers Benjamin Bass, PhD and Jason Frank, PhD. 
 
"Previous controlled studies have shown that SynGenX supports feed intake, weight gain, and gut health and wellness in young pigs," Dr. Bass says. "The product has also been shown to affect enteric bacteria concentrations and the immune response. The purpose of Dr. Probst Miller’s research was to evaluate how these effects may assist pigs in coping with both E. coli and Salmonella before they cause disease."
 
SynGenX is a natural nutritional health product used in swine diets. The DV Bioactives in SynGenX not only improve butyrate production, but also support a healthy bacterial balance to optimize immune function and overall health of weaned pigs.

"SynGenX," says Dan Mueller, Diamond V Swine Business development manager, "provides research-proven support for immunity, health, and performance in young pigs."